Company ProfilePremium

Yield10 Bioscience, Inc.

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Yield10 Bioscience, Inc. - Healthcare showcase

Year Founded & Workforce

1992

22 Employees

Industry

Healthcare

Services

Yield10 Crop Traits in Development
Y

Yield10 Bioscience, Inc. Employee Contacts

10 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Yield10 Bioscience, Inc. Overview

Company Headquarters: Massachusetts, US

Founded: 1992

Workforce: ~ 22

Company Working:

Yield10 Bioscience, Inc. changed its name from Metabolix Inc. to Yield10 Bioscience, Inc. in 2017. Yield10 Bioscience, Inc. is actively involved in developing and manufacturing high-quality seed traits for the agriculture and food industry. It concentrates on the development of products related to the agricultural bioscience segment in which crops such as corn, soybean, canola, wheat, and rice are main major focus areas of the company. It operates in only one business segment namely, Innovation Platform. Its investments in R&D are significantly high, and it has a strong product pipeline.

Strategy

Yield10 Bioscience, Inc. aims to deliver innovative products to farmers and help them increase the crop yield. The company is focused on establishing strategic partnerships globally for the evaluation of its seeds and traits for the commercial launch.

Company Snapshot

$1.2M

Revenue

22

Employees

1992

Founded

Massachusetts, US

Headquarters

SWOT Analysis

Strengths

  • Strong strategic alliances and collaborations
  • Well-developed in-house R&D capabilities
  • Strong presence in North America

Weaknesses

  • Financial instability due to continues loss
  • Government grants is the only source of income

Opportunities

  • New seed trait development for developing regions

Threats

  • Intense competition in the traits and seeds market
  • Changing regulatory scenario

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
August 2019ExpansionYield10 Bioscience, Inc. announced the expansion of its non-exclusive research license with Bayer for assessment of a Novel C3004 yield trait gene in soybean. This non-exclusive research license is expected to help the company to evaluate C3004 yield trait with respect to the commercial aspect.
Jan 2017AgreementYield10 Bioscience, Inc signed an agreement with the University of Missouri (US) for evaluation of oilseed crops Camelina, canola, and soybean. This was aimed to help the company check its commercial capabilities.

Product Offering

  • Yield10 Bioscience, Inc.
    • Yield10 Crop Traits in Development

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Total Revenue fell from USD 1.2 Mn in 2016 to USD 0.6 Mn in 2018.
Yield10 Bioscience, Inc. — By Business Segment
Series (USD Mn)201620172018
Total Revenue1.20.90.6
R&D Expenses5.74.64.8

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.